603235 天新药业
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额490,550499,656729,212606,613818,631
投资活动产生之现金流量净额(154,008)(1,540,670)(303,146)(455,342)(239,543)
筹资活动产生之现金流量净额(50,707)(240,193)(215,595)1,162,448(885,961)
汇率变动对现金及现金等价物的影响3,38551,70627,76863,374(19,983)
现金及现金等价物净增加/(减少)289,220(1,229,502)238,2401,377,094(326,856)
期初现金及现金等价物余额1,078,2672,307,7692,069,529692,4361,019,292
期末现金及现金等价物余额1,367,4871,078,2672,307,7692,069,529692,436